Literature DB >> 19626273

Regression of chronic posterior leukoencephalopathy after stop of methotrexate treatment.

Gabriella Marcon1, Anna Rita Giovagnoli, Paola Mangiapane, Alessandra Erbetta, Fabrizio Tagliavini, Floriano Girotti.   

Abstract

Posterior reversible leukoencephalopathy (PRLE) is a neurological disorder caused by a variety of pathological conditions such as high doses or long-term low-doses of immunosuppressive therapy. PRLE associated with methotrexate (MTX) is well known but it was rarely observed in adult patients submitted to long-term low-dose administration via the oral route. Here we report the case of a patient affected by psoriasis, treated by chronic oral low-dose of MTX, who presented with limb ideomotor apraxia. Magnetic resonance (MRI) of the brain showed, on T2-weighted images, a diffuse hyperintensity involving bilaterally the white matter of the occipital, parietal and frontal lobes. MTX treatment was stopped and, at the 6-month follow-up, the neuropsychological performances was improved. Two years later, the neuropsychological profile was normal and MRI showed a regression of the white matter abnormalities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626273     DOI: 10.1007/s10072-009-0119-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

1.  Memory encoding and hippocampally-based novelty/familiarity discrimination networks.

Authors:  Reza Habib; Anthony R McIntosh; Mark A Wheeler; Endel Tulving
Journal:  Neuropsychologia       Date:  2003       Impact factor: 3.139

2.  Reversible posterior leucoencephalopathy during oral treatment with methotrexate.

Authors:  Dimitri Renard; Rene Westhovens; Erik Vandenbussche; Rik Vandenberghe
Journal:  J Neurol       Date:  2004-02       Impact factor: 4.849

3.  Visuomotor ataxia.

Authors:  P Rondot; J de Recondo; J L Dumas
Journal:  Brain       Date:  1977-06       Impact factor: 13.501

Review 4.  Cyclosporine neurotoxicity: a review.

Authors:  J M Gijtenbeek; M J van den Bent; C J Vecht
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

5.  Methotrexate disposition following disruption of the blood-brain barrier.

Authors:  S J Markowsky; C L Zimmerman; D Tholl; I Soria; R Castillo
Journal:  Ther Drug Monit       Date:  1991-01       Impact factor: 3.681

6.  Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment.

Authors:  Joong-Seok Kim; Kwang-Soo Lee; Sung-Chul Lim; Jae-Young Ahn; In-Uk Song; Yeong-In Kim; Bum-Soo Kim; Hee-Tae Kim
Journal:  Mov Disord       Date:  2007-05-15       Impact factor: 10.338

7.  Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases.

Authors:  R B Schwartz; K M Jones; P Kalina; R L Bajakian; M T Mantello; B Garada; B L Holman
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

Review 8.  Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity.

Authors:  J Grosflam; M E Weinblatt
Journal:  Curr Opin Rheumatol       Date:  1991-06       Impact factor: 5.006

9.  Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia.

Authors:  J E Rubnitz; M V Relling; P L Harrison; J T Sandlund; R C Ribeiro; G K Rivera; S J Thompson; W E Evans; C H Pui
Journal:  Leukemia       Date:  1998-08       Impact factor: 11.528

10.  Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.

Authors:  L J Rubinstein; M M Herman; T F Long; J R Wilbur
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

View more
  4 in total

Review 1.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

2.  Clinical reasoning: progressive visuospatial problems in a 71-year-old man.

Authors:  Mkael Symmonds; Wilhelm Küker; Ursula G Schulz
Journal:  Neurology       Date:  2014-07-01       Impact factor: 9.910

Review 3.  Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature.

Authors:  Anmol Dhillon; Celso Velazquez; Chokkalingam Siva
Journal:  Rheumatol Int       Date:  2012-07-24       Impact factor: 2.631

4.  Leukoencephalopathy due to oral methotrexate.

Authors:  I González-Suárez; M J Aguilar-Amat; M Trigueros; A M Borobia; A Cruz; J Arpa
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.